Online inquiry

IVTScrip™ mRNA-Human APBB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16198MR)

This product GTTS-WK16198MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the APBB1 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001164.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 322
UniProt ID O00213
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APBB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16198MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27764MR IVTScrip™ mRNA-Human ARNTL2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARNTL2
GTTS-WK11117MR IVTScrip™ mRNA-Human AARD, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AARD
GTTS-WK28725MR IVTScrip™ mRNA-Human ASPN, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASPN
GTTS-WK7028MR IVTScrip™ mRNA-Human D105, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA D105
GTTS-WK3321MR IVTScrip™ mRNA-Human Go-alpha, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Go-alpha
GTTS-WK26931MR IVTScrip™ mRNA-Human ASXL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASXL1
GTTS-WK23499MR IVTScrip™ mRNA-Human ARHGAP4, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP4
GTTS-WK23827MR IVTScrip™ mRNA-Human ARID5A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARID5A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →